Aytu BioPharma Inc (NAS:AYTU)
$ 2.53 -0.04 (-1.56%) Market Cap: 15.11 Mil Enterprise Value: 12.30 Mil PE Ratio: 0 PB Ratio: 0.46 GF Score: 40/100

Aytu Biopharma Inc at Lytham Partners Fall Investor Conference Transcript

Oct 17, 2023 / 11:00AM GMT
Release Date Price: $3.14 (+2.95%)
Roger Weiss
Lytham Partners - VP

Hello, everyone, and thank you for joining us during the Lytham Partners fall 2023 investor select conference. My name is Roger White, I'm a Vice President of Lytham Partners. In this presentation, we welcome Aytu Biopharma, Nasdaq ticker symbol AYTU. And today we have with us Chief Executive Officer, Josh Disbrow.

Before we begin, I want to remind everybody that management is available for one-on-one meetings later this week. If you have not already signed up, please send me an e-mail at [email protected], or visit www.lythampartners.com/virtual and click the one-on-one meeting request button.

Questions & Answers

Roger Weiss
Lytham Partners - VP

Alright Josh, let's begin. Could you please introduce yourself and give us a brief overview of Aytu?

Josh Disbrow
Aytu Biopharma Inc - Chairman&CEO

Sure. Happy to, Roger. Thanks for having us at the Lytham conference, and glad to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot